Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Scott

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
The Journal of Rheumatology|April 1, 2005
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritisVibeke Strand, David L Scott, Paul Emery, et al.
Health Technology Assessment (Winchester, England)|October 30, 2014
Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviewsDavid L Scott, Fowzia Ibrahim, Vern Farewell, et al.
Arthritis Research & Therapy|November 5, 2021
Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trialSook Yan Lee, Fowzia Ibrahim, Brian D M Tom, et al.
Arthritis Research & Therapy|January 18, 2014
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trialSeth D Seegobin, Margaret H Y Ma, Chanaka Dahanayake, et al.
Cancer Research|May 31, 2002
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinomaThomas S Griffith, Jonathan M Fialkov, David L Scott, et al.
Clinical and Experimental Rheumatology|February 5, 2016
A randomised trial evaluating anakinra in early active rheumatoid arthritisIan C Scott, Fowzia Ibrahim, Gemma Simpson, et al.
Health Technology Assessment (Winchester, England)|December 6, 2017
The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysisAllan Wailoo, Emma S Hock, Matt Stevenson, et al.
BMC Musculoskeletal Disorders|January 29, 2016
Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studiesAneela N Mian, Fowzia Ibrahim, Ian C Scott, et al.
Trials|December 10, 2017
Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trialNaomi H Martin, Fowzia Ibrahim, Brian Tom, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical dataNicola J Gullick, Aneela N Mian, Fowzia Ibrahim, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
The Journal of Rheumatology|April 1, 2005
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritisVibeke Strand, David L Scott, Paul Emery, et al.
Health Technology Assessment (Winchester, England)|October 30, 2014
Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviewsDavid L Scott, Fowzia Ibrahim, Vern Farewell, et al.
Arthritis Research & Therapy|November 5, 2021
Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trialSook Yan Lee, Fowzia Ibrahim, Brian D M Tom, et al.
Arthritis Research & Therapy|January 18, 2014
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trialSeth D Seegobin, Margaret H Y Ma, Chanaka Dahanayake, et al.
Cancer Research|May 31, 2002
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinomaThomas S Griffith, Jonathan M Fialkov, David L Scott, et al.
Clinical and Experimental Rheumatology|February 5, 2016
A randomised trial evaluating anakinra in early active rheumatoid arthritisIan C Scott, Fowzia Ibrahim, Gemma Simpson, et al.
Health Technology Assessment (Winchester, England)|December 6, 2017
The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysisAllan Wailoo, Emma S Hock, Matt Stevenson, et al.
BMC Musculoskeletal Disorders|January 29, 2016
Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studiesAneela N Mian, Fowzia Ibrahim, Ian C Scott, et al.
Trials|December 10, 2017
Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trialNaomi H Martin, Fowzia Ibrahim, Brian Tom, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical dataNicola J Gullick, Aneela N Mian, Fowzia Ibrahim, et al.
Pageof 14